GH Research PLC (GHRS) 13F Investor Activity Report (Q2 2026)

GHRS ranks #5517 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

GHRS is a top-conviction position for Lynx1 Capital Management LP — at 41.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Lynx1 Capital Management LP has added to its GHRS position for two straight quarters, increasing it by $224.4M to reach $356.5M today.

Marshall Wace, LLP has trimmed its GHRS position for two straight quarters, cutting it by $1.8M while still holding $1.3M.

GHRS is up 2.6% today, and institutions have been net buyers of $199.1M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

GHRS reported a net loss of $48.3M in its latest fiscal year.

• Not yet profitable — net loss of $48.3M in the latest fiscal year
• Net income declined year over year, from -$39.0M to -$48.3M
• Operating cash flow was negative, using $43.6M in cash
• Current ratio of 34.13x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.03x equity — within a conventional range